Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
Merck & Co., Inc. (MRK) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 291 options to buy @ $102.95, valued at $30k
10/03/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 79 options to buy @ $102.95, valued at $8.1k
10/03/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 437 options to buy @ $102.95, valued at $45k
10/03/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 291 options to buy @ $102.95, valued at $30k
08/15/2023 4 MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 4,250 shares @ $109.01, valued at $463.3k
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/04/2023 4 Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Exercised 36,901 shares @ $105.7, valued at $3.9M
Paid exercise price by delivering 17,989 shares @ $105.7, valued at $1.9M
Exercised 36,901 restricted stock units @ $0
08/04/2023 4 MIZELL STEVEN (EVP, Chief HR Officer) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 4,500 shares @ $105.4891, valued at $474.7k
08/03/2023 144 Form 144 - Report of proposed sale of securities:
08/03/2023 4 Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.
Txns: Sold 30 shares @ $107.371, valued at $3.2k
Sold 59 shares @ $107.371, valued at $6.3k
08/01/2023 8-K Quarterly results
07/05/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 260 options to buy @ $115.39, valued at $30k
07/05/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 70 options to buy @ $115.39, valued at $8.1k
07/05/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 390 options to buy @ $115.39, valued at $45k
07/05/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 260 options to buy @ $115.39, valued at $30k
06/30/2023 4 Romanelli Joseph (President, Human Health Int?l) has filed a Form 4 on Merck & Co., Inc.
Txns: Bought 59 shares @ $109.67, valued at $6.5k
Bought 107 shares @ $109.54, valued at $11.7k
Bought 30 shares @ $109.39, valued at $3.3k
Bought 56 shares @ $110.96, valued at $6.2k
Bought 7 shares @ $109.04, valued at $763.3
Bought 11 shares @ $109.2, valued at $1.2k
Bought 136 shares @ $105.47, valued at $14.3k
Sold 35 shares @ $104.65, valued at $3.7k
Bought 3 shares @ $113.68, valued at $341
05/31/2023 4 LAVIZZO-MOUREY RISA J (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 THULIN INGE G (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 WENDELL PETER C (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Warden Kathy J (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Seidman Christine E (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 RUSSO PATRICIA F (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Rothman Paul (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Mayo Stephen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 GLOCER THOMAS H (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Craig Pamela J. (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 Coe Mary Ellen (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/31/2023 4 BAKER DOUGLAS M JR (Director) has filed a Form 4 on Merck & Co., Inc.
Txns: Granted 1,981 options to buy @ $111.07, valued at $220k
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/18/2023 PX14A6G Form PX14A6G - Notice of exempt solicitation submitted by non-management:
05/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "4.050% Notes due 2028 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2028 Notes",
"4.300% Notes due 2030 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2030 Notes",
"4.500% Notes due 2033 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2033 Notes",
"4.900% Notes due 2044 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2044 Notes",
"5.000% Notes due 2053 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2053 Notes",
"5.150% Notes due 2063 Officers’ Certificate of the Company dated May 17, 2023, including form of the 2063 Notes",
"Opinion and Consent of Jennifer Zachary, Esq., Executive Vice President and General Counsel of the Company"
05/10/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
05/08/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy